Orchid Pharma jumps on getting EIR from USFDA for Tamil Nadu plant

19 Apr 2017 Evaluate

Orchid Pharma is currently trading at Rs. 37.40, up by 0.85 points or 2.33% from its previous closing of Rs. 36.55 on the BSE.

The scrip opened at Rs. 37.00 and has touched a high and low of Rs. 37.90 and Rs. 36.75 respectively. So far 308213 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 45.90 on 22-Apr-2016 and a 52 week low of Rs. 23.70 on 22-Nov-2016.

Last one week high and low of the scrip stood at Rs. 39.70 and Rs. 31.90 respectively. The current market cap of the company is Rs. 332.73 crore.

The promoters holding in the company stood at 28.35%, while Institutions and Non-Institutions held 5.28% and 66.37% respectively.

Orchid Pharma has received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection of the formulation manufacturing facility located at Plot Nos B5 (Pt) & B6 (Pt), SIPCOT Industrial Park, Irungattukottai, Sriperumbudur, Kancheepuram District in Tamil Nadu, India. The facility was inspected by USFDA in December 2016.

Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.

 

Orchid Pharma Share Price

1035.75 11.10 (1.08%)
28-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.